Benzinga | May 7, 2021 07:05AM EDT

Aclaris Therapeutics Q1 EPS $(0.57) Down From $(0.37) YoY, Sales $1.78B Up From $1.41M YoY

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.57) per share. This is a 54.05 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $1.78 billion in sales this quarter. This is a 126.20K percent increase over sales of $1.41 million the same period last year.